Clarivate officer proposes $190K share sale
The proposed shares are listed as restricted stock and performance shares acquired upon vesting.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Clarivate PLC officer Jonathan Mark Collins submitted a notice proposing the sale of 84,663 common shares, with an approximate sale date of November 4, 2026. Morgan Stanley Smith Barney LLC is named as the broker, and the notice gives an aggregate market value of $190,491.75 for the proposed sale.
The notice lists 68,913 restricted-stock shares and 15,750 performance shares among the securities to be sold; remarks say these securities were acquired upon vesting. Restricted-stock vesting is reported from March 1, 2022 through March 15, 2026, and performance-share vesting from March 4, 2025 through February 18, 2026. It also reports that Collins sold 82,552 common shares on November 3, 2026, for an aggregate market value of $165,351.66 during the preceding three months.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.